NCT06513884 2025-06-22A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal CancerHookipa Biotech GmbHPhase 2/3 Withdrawn
NCT00412776 2015-12-23Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck CancerSesen Bio, Inc.Phase 2/3 Terminated165 enrolled
NCT00363441 2012-01-19A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and NeckAHS Cancer Control AlbertaPhase 2/3 Withdrawn